Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial.

Respiratory Investigation
Arata AzumaSENSCIS Trial Investigators

Abstract

In the SENSCIS trial in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD), nintedanib reduced the rate of decline in forced vital capacity (FVC) (mL/year) over 52 weeks by 44% in comparison with placebo, with manageable adverse events in most patients. We analyzed the efficacy and safety of nintedanib in patients of Asian race. Patients with SSc-ILD were randomized to receive nintedanib or placebo. The outcomes over 52 weeks were analyzed in Asian versus non-Asian patients. Of the 288 patients in each treatment group, 62 (21.5%) in the nintedanib group and 81 (28.1%) in the placebo group were Asian; 90.2% of the Asian patients were enrolled in Asian countries. In the placebo group, the rate of FVC decline over 52 weeks was consistent between Asian and non-Asian patients (-99.9 and -90.6 mL/year, respectively). The effect of nintedanib on reducing the rate of FVC decline over 52 weeks was consistent between Asian (difference, 44.3 mL/year [95% CI: -32.8, 121.4]) and non-Asian patients (difference, 39.0 mL/year [95% CI: -5.1, 83.1]) (treatment-by-time-by-subgroup interaction, p = 0.91). Diarrhea was the most frequent adverse event and was reported in similar proportions of Asian and non-Asian patient...Continue Reading

References

Sep 1, 1991·Respiratory Medicine·P W JonesC M Baveystock
Aug 1, 2009·Arthritis and Rheumatism·Sogol AmjadiUNKNOWN Investigators of the D-Penicillamine, Human Recombinant Relaxin, and Oral Bovine Type I Collagen Clinical Trials
Jun 30, 2012·The European Respiratory Journal·Philip H QuanjerUNKNOWN ERS Global Lung Function Initiative
Jul 12, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Hiroyuki TaniguchiDong S Kim
Dec 21, 2016·Respirology : Official Journal of the Asian Pacific Society of Respirology·Arata AzumaToshihiro Nukiwa
May 19, 2017·Journal of Scleroderma and Related Disorders·Dinesh KhannaChristopher P Denton
Aug 25, 2017·Annals of the Rheumatic Diseases·Muriel ElhaiUNKNOWN EUSTAR group
Nov 15, 2017·Pulmonary Pharmacology & Therapeutics·Ulrike SchmidMatthias Freiwald
Nov 10, 2018·Annals of the Rheumatic Diseases·Elizabeth R VolkmannUNKNOWN SLS I and SLS II study groups
Mar 3, 2019·The Journal of Rheumatology·Haifa Al-SheikhSindhu R Johnson
May 22, 2019·The New England Journal of Medicine·Oliver DistlerUNKNOWN SENSCIS Trial Investigators
Jul 17, 2019·American Journal of Respiratory and Critical Care Medicine·Anna-Maria Hoffmann-VoldØyvind Molberg
Jul 23, 2019·Respirology : Official Journal of the Asian Pacific Society of Respirology·Jin Woo SongBruno Crestani
Mar 22, 2020·ACR Open Rheumatology·Melody P ChungLorinda Chung
Aug 8, 2020·Annals of the Rheumatic Diseases·James R SeiboldUNKNOWN SENSCIS trial investigators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.